Resources Contact Us Home
Oligoadenylate synthetase (OAS)

Image Number 2 for United States Patent #8133710.

The invention describes novel pharmaceutical compositions for the treatment of virus infections and cancer. The pharmaceutical compositions include mutant oligoadenylate synthetases (OAS) that have either enhanced cell permeability, reduced oxidative potential, improved antiviral activity, improved enzymatic activity, or absent enzymatic activity. The pharmaceutical compositions have improved drug properties and retain or have enhanced antiviral activity relative to their native forms. The pharmaceutical compositions further include chemically modified oligoadenylate synthetases, such chemical modifications being designed to increase serum stability and reduce immunogenicity in vivo. Such chemical modifications further increase drug stability and manufacturability in vitro. Compositions composed of more than ninety novel modifications are described. Also described are antibodies to polypeptides of the invention.

  Recently Added Patents
Hydrogen generation device and fuel cell system
Managing breakpoints in a multi-threaded environment
Fuel cell module, manufacturing method thereof and unit containing several of the latter
Image forming apparatus
Device and method to automatically configure port forwarding
High brightness laser diode module
Wafer processing method and system using multi-zone chuck
  Randomly Featured Patents
Transfer system
Image reading apparatus
Cultural knowledge board game
Electrode plates for lead-acid battery and their manufacturing method
Method and system for articulated character head actuation and control
Method and system for steering a collimated light beam with a pivotable mirror
Regulation of meiosis using sterols
Air freshening and deodorizing system
Apparatus and method for analysis of expired breath
Local interconnection method and structure for use in semiconductor device